Caris Life Sciences completes IPO of 23.5M shares at $21.00, raising $494.1M gross

Caris Life Sciences, Inc.

IPO of 23,529,412 shares of common stock at $21.00 per share closed June 20, 2025.
Gross proceeds of $494.1 million before underwriting discounts and estimated offering expenses.
Amended and restated certificate of formation and bylaws became effective upon IPO closing.
Shares trade on Nasdaq under ticker CAI.

item 5.03item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.